# Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy

> **NCT06717412** · NA · RECRUITING · sponsor: **Wang Yusheng** · enrollment: 146 (estimated)

## Conditions studied

- Retinopathy of Prematurity (ROP)

## Interventions

- **DRUG:** Conbercept

## Key facts

- **NCT ID:** NCT06717412
- **Lead sponsor:** Wang Yusheng
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-29
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 146 (ESTIMATED)
- **Last updated:** 2025-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06717412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06717412, "Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06717412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*